ℹ️ Compiled from public regulatory records · Last regulator revision: May 21, 2026🚩 Report this page
Linerixibat
Other Drugs For Bile Therapy
GB MHRA
- Drug class
- Other Drugs For Bile Therapy
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Linerixibat is an active pharmaceutical ingredient in the Other Drugs For Bile Therapy group (A05AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | May 21, 2026 |
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]MHRA (UK) · PL194940330 · revised May 21, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.